Bernstein Harold

CIK 00020501721 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0002050172

Recent Transactions

20 trades

Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-02-02$47.23/sh−100→ 0 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-02-02$44.20/sh−600→ 14,400 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-02-02$10.42/sh+15,000→ 15,000 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-02-02−15,000→ 297,407 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-02-02$46.37/sh−5,936→ 100 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-02-02$45.89/sh−8,364→ 6,036 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-07$40.20/sh−25,156→ 0 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-07$10.42/sh+25,156→ 25,156 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-01-07−25,156→ 312,407 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-01-05−412→ 337,563 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-05$10.42/sh+412→ 412 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-05$40.00/sh−412→ 0 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-01-02−4,432→ 337,975 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-02$40.43/sh−4,432→ 0 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-02$10.42/sh+4,432→ 4,432 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-12-29$40.34/sh−27,800→ 17,200 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-12-29$10.42/sh+45,000→ 45,000 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2025-12-29−45,000→ 342,407 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-12-29$40.93/sh−17,200→ 0 total
Award
Maze Therapeutics, Inc.$MAZE
Restricted Stock Units
2025-09-22+40,000→ 40,000 total

Companies

Maze Therapeutics, Inc.
President, R&D & CMO
$MAZE

Recent Filings

Address

C/O MAZE THERAPEUTICS, INC. 171 OYSTER POINT BOULEVARD, SUITE 300

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov